Endurant Capital Management LP Boston Scientific Corp Transaction History

Endurant Capital Management LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $1.06 Million - $1.27 Million	-21,883 Reduced 35.88%	39,108 $2.26 Million
Q2 2023 Aug 14, 2023	BUY	$49.72 - $54.64 $3.03 Million - $3.33 Million	60,991 New	60,991 $3.3 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $14.7 Million - $19.7 Million	418,165 New	418,165 $15.6 Million
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $6.12 Million - $7.02 Million	-158,702 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$35.27 - $39.67 $5.6 Million - $6.3 Million	158,702 New	158,702 $6.13 Million
Q3 2020 Nov 16, 2020	SELL	$34.44 - $42.23 $3.66 Million - $4.49 Million	-106,338 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $3.21 Million - $4.16 Million	106,338 New	106,338 $3.73 Million
Q1 2019 May 15, 2019	SELL	$32.91 - $40.75 $1.01 Million - $1.25 Million	-30,560 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $1.26 Million - $1.56 Million	-39,847 Reduced 56.6%	30,560 $1.08 Million
Q3 2018 Nov 14, 2018	SELL	$32.83 - $38.63 $79,908 - $94,025	-2,434 Reduced 3.34%	70,407 $2.71 Million
Q2 2018 Aug 14, 2018	SELL	$26.84 - $34.32 $8.45 Million - $10.8 Million	-314,857 Reduced 81.21%	72,841 $2.38 Million
Q1 2018 May 15, 2018	BUY	$25.2 - $28.54 $1.14 Million - $1.29 Million	45,100 Added 13.16%	387,698 $10.6 Million
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $3.27 Million - $3.94 Million	132,100 Added 62.76%	342,598 $8.49 Million
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $5.53 Million - $6.14 Million	210,498	210,498 $6.14 Million

1,589

1.19B

6.83M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $150B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.